Secondary adrenal insufficiency (SAI) is an endocrine disorder due to impaired secretion of ACTH resulting from any disease affecting the pituitary gland. Glucocorticoid replacement therapy is mandatory to ensure patient survival, haemodynamic stability, and quality of life. In fact, a correct dose adjustement is mandatory due to the fact that inappropriately low doses expose patients to hypoadrenal crisis, while inappropriately high doses contribute to glucose metabolic and cardiovascular deterioration. This review analyses the current evidence from available publications on the epidemiology and aetiology of SAI and examines the association between glucocorticoid replacement therapy and glucometabolic and cardiovascular effects.
Keywords: Craniopharyngiomas; Diabetes insipidus; Germinoma; Histiocytosis; Hypophysitis; Hypopituitarism; Metastasis; Pit-NET; Pituitary adenoma; Pituitary neuroendocrine tumors.
© 2024. The Author(s).